DuChemBIO Co.,Ltd. (XKON: 176750)

Market Cap	430.17B
Revenue	n/a
Net Income	n/a
Shares Out	26.99M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,811
Open	14,510
Previous Close	14,510
Day's Range	14,500 - 15,300
52-Week Range	5,050 - 19,570
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DuChemBIO Co.,Ltd.

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2002
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 176750